Ningbo Menovo Pharmaceutical Co., Ltd. (603538.SS)
CNY 13.35
(0.3%)
CNY 13.35
(0.3%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.21 Billion | 1.45 Billion | 1.25 Billion | 1.19 Billion | 1.18 Billion | 848.96 Million |
| Cost of Revenue | 873.79 Million | 872.79 Million | 788.92 Million | 758.57 Million | 727.62 Million | 572.49 Million |
| Gross Profit | 342.7 Million | 584.18 Million | 469.21 Million | 435.12 Million | 452.57 Million | 276.46 Million |
| Operating Expenses | 323.95 Million | 341.37 Million | 280.99 Million | 235.97 Million | 236.23 Million | 171.24 Million |
| Selling, General and Administrative Expenses | 220.09 Million | 126.83 Million | 81.86 Million | 64.01 Million | 80.48 Million | 52.04 Million |
| Research and Development Expenses | 95.29 Million | 98.15 Million | 88.31 Million | 62.04 Million | 52.96 Million | 39.2 Million |
| Other Expenses | 8.56 Million | 116.37 Million | 110.81 Million | 109.9 Million | 102.78 Million | -5.79 Million |
| Cost and Expenses | 1.19 Billion | 1.21 Billion | 1.06 Billion | 994.54 Million | 963.86 Million | 743.74 Million |
| Operating Income | 18.74 Million | 405.32 Million | 187.9 Million | 215.53 Million | 189.73 Million | 112.55 Million |
| Interest Expense | 29.97 Million | 27.44 Million | 27.16 Million | 26.19 Million | 23.38 Million | 19.61 Million |
| Income Tax Expense | -8.22 Million | 16.54 Million | 22.22 Million | 41.6 Million | 26.44 Million | 1.69 Million |
| Earnings before Tax | 7.95 Million | 384.16 Million | 180.29 Million | 214.66 Million | 187.24 Million | 106.75 Million |
| Net Income | 11.58 Million | 338.85 Million | 142.52 Million | 155.96 Million | 150.9 Million | 96.34 Million |
| Earnings Per Share Basic | 0.05 | 1.61 | 0.69 | 0.76 | 0.75 | 0.48 |
| Earnings Per Share Diluted | 0.05 | 1.49 | 0.66 | 0.76 | 0.73 | 0.47 |
| Weighted Average Shares Outstanding | 231.71 Million | 210.4 Million | 207.4 Million | 205.55 Million | 201.64 Million | 200.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 231.71 Million | 227.34 Million | 216.42 Million | 205.55 Million | 205.39 Million | 203.94 Million |
| Gross Margin | 0.28 | 0.40 | 0.37 | 0.36 | 0.38 | 0.33 |
| EBIT Margin | 0.13 | 0.37 | 0.25 | 0.31 | 0.24 | 0.22 |
| Profit Margin | 0.01 | 0.23 | 0.11 | 0.13 | 0.13 | 0.11 |
| EBITDA | 155.45 Million | 498.48 Million | 301.57 Million | 321.39 Million | 275.05 Million | 158.39 Million |
| Earnings Before Tax Margin | 0.02 | 0.28 | 0.15 | 0.18 | 0.16 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 336.93 Million | 345.11 Million | 262.76 Million | 1.21 Billion | 287.96 Million | 346.27 Million |
| Cost of Revenue | 218.06 Million | 260.94 Million | 167.53 Million | 840.93 Million | 213.99 Million | 221.35 Million |
| Gross Profit | 118.86 Million | 84.17 Million | 95.23 Million | 375.56 Million | 73.97 Million | 124.91 Million |
| Operating Expenses | 79.62 Million | 75 Million | 65.29 Million | 291.17 Million | 80.42 Million | 87.47 Million |
| Selling, General and Administrative Expenses | 56 Million | 1.56 Million | 49.95 Million | - | -53.83 Million | 111.17 Million |
| Research and Development Expenses | 22.1 Million | 26.53 Million | 15.82 Million | - | 30.94 Million | 28.72 Million |
| Other Expenses | -1.51 Million | 20.02 Million | -1.27 Million | -10.79 Million | -9.82 Million | 37.66 Million |
| Cost and Expenses | 297.68 Million | 335.94 Million | 232.82 Million | 1.13 Billion | 294.42 Million | 308.83 Million |
| Operating Income | 39.24 Million | 7.87 Million | 21.69 Million | 18.74 Million | -38.49 Million | 23.23 Million |
| Interest Expense | 5.25 Million | 8.24 Million | 7.19 Million | 29.06 Million | 8.14 Million | 6.94 Million |
| Income Tax Expense | 8.23 Million | 1.9 Million | 4.64 Million | -8.22 Million | -4.53 Million | -2.94 Million |
| Earnings before Tax | 51.93 Million | 7.36 Million | 20.41 Million | 7.95 Million | -48.32 Million | 22.53 Million |
| Net Income | 44.3 Million | 4.89 Million | 14.04 Million | 11.58 Million | -42.95 Million | 23.68 Million |
| Earnings Per Share Basic | 0.21 | 0.02 | 0.07 | - | -0.14 | 0.11 |
| Earnings Per Share Diluted | 0.21 | 0.02 | 0.07 | - | -0.14 | 0.10 |
| Weighted Average Shares Outstanding | 211.98 Million | 200.61 Million | 200.61 Million | 231.71 Million | 297.56 Million | 211.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 211.98 Million | 200.61 Million | 200.61 Million | 231.71 Million | 297.55 Million | 236.84 Million |
| Gross Margin | 0.35 | 0.24 | 0.36 | 0.31 | 0.26 | 0.36 |
| EBIT Margin | 0.17 | 0.07 | 0.08 | - | -0.11 | 0.24 |
| Profit Margin | 0.13 | 0.01 | 0.05 | 0.01 | -0.15 | 0.07 |
| EBITDA | 57.18 Million | 22.46 Million | 20.78 Million | - | -31.9 Million | 81.65 Million |
| Earnings Before Tax Margin | 0.12 | 0.02 | 0.08 | 0.02 | -0.13 | 0.07 |
PEO
016360
OSCR
RANASUG
HAA1
SINTERCOM